Theranostics 2022; 12(12):5334. doi:10.7150/thno.74941 This issue

Erratum

Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice: Erratum

Ya-Jie Lv1,4*, Yi Yang1,3*, Bing-Dong Sui1,2*, Cheng-Hu Hu1,2*, Pan Zhao1,2, Li Liao1,2, Ji Chen1, Li-Qiang Zhang1,2, Tong-Tao Yang5, Shao-Feng Zhang3✉, Yan Jin1,2✉

1. State Key Laboratory of Military Stomatology, Center for Tissue Engineering, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
2. Xi'an Institute of Tissue Engineering and Regenerative Medicine, Xi'an, Shaanxi 710032, China.
3. State Key Laboratory of Military Stomatology, Department of Prosthodontics, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
4. Department of Dermatology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shannxi, 710069, China.
5. Department of Orthopaedics, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shannxi, 710069, China.
*These authors contributed equally to this manuscript.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Lv YJ, Yang Y, Sui BD, Hu CH, Zhao P, Liao L, Chen J, Zhang LQ, Yang TT, Zhang SF, Jin Y. Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice: Erratum. Theranostics 2022; 12(12):5334. doi:10.7150/thno.74941. Available from https://www.thno.org/v12p5334.htm

File import instruction

Corrected-article in Theranostics, Volume 8, 2387